Complement-dependent platelet degradation and anaphylactoid shock in mice induced by lipopolysaccharide carrying the mannose homopolymer

Abstract

Intravenous injection of specified bacterial lipopolysaccharides (LPSs) induced anaphylactoid shock in mice of various strains, including LPS-resistant C3H/HeJ. The reaction was accompanied by occasional mortality of mice within 1 h. Prior to shock, rapid accumulation of blood platelets in the lungs and liver followed by degradation of platelets (or release of their contents) and tissue destruction were observed. In this study, LPS specimens carrying mannose-homopolymer (MHP), which markedly activate the human complement system through the lectin pathway, induced marked platelet degradation and anaphylactoid shock in BALB/c mice. In contrast, in C5-deficient DBA/2 mice, the platelet degradation and anaphylactoid reactions did not occur. Anti-complement agent K-76 COOH (C5 inhibitor) protected BALB/c mice from mortality in the anaphylactoid reaction. K-76 COOH also inhibited platelet degradation, but not accumulation, induced by LPS in mice. Based on these findings, we postulated that strong complement activation by specified LPS preparations induced degradation of platelets that have accumulated in the lungs and liver, resulting in acute inflammation accompanied by severe tissue destruction, especially in the lungs, which in turn leads to anaphylactoid reaction.

References

Takada H. , Galanos C. Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice. Infect Immun 1987; 55: 409—413.

Takada H. , Hirai H. , Fujiwara T. , Koga T. , Ogawa T. , Hamada S. Bacteroides lipopolysaccharides (LPS) induce anaphylactoid and lethal reactions in LPS-responsive and -nonresponsive mice primed with muramyl dipeptide. J Infect Dis 1990; 162: 428—434.

Shibazaki M. , Nakamura M. , Endo Y. Biphasic, organ-specific, and strain-specific accumulation of platelets induced in mice by a lipopolysaccharide from Escherichia coli and its possible involvement in shock. Infect Immun 1996; 64: 5290—5294.

Endo Y. , Shibazaki M. , Nakamura M. , Takada H. Contrasting effects of lipopolysaccharides (endotoxins) from oral black-pigmented bacteria and Enterobacteriacea on platelets, a major source of serotonin, and on histamine-forming enzyme in mice. J Infect Dis 1997; 175: 1404—1412.

Ooi YM , Colten HR Genetic defect in secretion of complement C5 in mice. Nature 1979; 282: 207—208.

Yokochi T. , Inoue Y. , Kimura Y. , Kato N. Strong interaction of lipopolysaccharides possessing the mannose homopolysaccharides with complement and its relation to adjuvant action. J Immunol 1990; 144: 3106—3110.

Jiang G-Z. , Sugiyama T. , Kato Y. , Koide N. , Yokochi T. Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation. Infect Immun 1995 ; 63: 2537—2540.

Matsushita M. , Thiel S. , Jensenius JC , Terai I. , Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 2000; 165: 2637—2642.

Paeng N. , Kido N. , Schmidt G. et al. Augmented immunological activities of recombinant lipopolysaccharide possessing the mannose homopolymer as the O-specific polysaccharide. Infect Immun 1996; 64: 305—309.

10.

Hong K. , Kinoshita T. , Miyazaki W. , Izawa T. , Inoue K. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade. J Immunol 1979; 122: 2418—2423.

11.

Endo Y. , Nakamura M. The effect of lipopolysaccharide, interleukin-1 and tumour necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse . Br J Pharmacol 1992; 105: 613—619.

12.

Mayer MM Complement and complement fixation. In: Kabat EA , Mayer MM. (eds) Experimental Immunochemistry. Illinois: Charles C Thomas, 1961; 133—240.